Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis

ConclusionsGoshajinkigan tended to prevent persistence but not severity of CIPN. Higher quality trials using multiple measures are needed in the future to clarify the preventive effect ofGoshajinkigan and to assess the various aspects of CIPN.

http://link.springer.com/10.1007/s10147-017-1229-4

Source: International Journal of Clinical Oncology - December 21, 2017 Category: Cancer & Oncology Source Type: research